Literature DB >> 21955624

Altered eosinophil proteome in a patient with hypereosinophilia from acute fascioliasis.

Christof Straub1, Jason P Burnham, A Clinton White, Konrad Pazdrak, Cesar Sanchez, Luis Carlos Watanabe, Alexander Kurosky, Martín Montes.   

Abstract

We used comparative proteomics to analyze eosinophils from a patient with hypereosinophilia due to fascioliasis. Using 2-dimensional electrophoresis and mass spectrometry, we demonstrated that the eosinophil proteome was significantly altered compared to those of healthy controls.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21955624      PMCID： PMC3209040          DOI： 10.1128/CVI.05373-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  13 in total

1.  The human eosinophil proteome. Changes induced by birch pollen allergy.

Authors:  Charlotte Woschnagg; Jens Forsberg; Ake Engström; Federico Odreman; Per Venge; Rodolfo C Garcia
Journal:  J Proteome Res       Date:  2009-06       Impact factor: 4.466

2.  Toward the Proteome of the Human Peripheral Blood Eosinophil.

Authors:  Christof Straub; Konrad Pazdrak; Travis W Young; Susan J Stafford; Zheng Wu; John E Wiktorowicz; Anthony M Haag; Robert D English; Kizhake V Soman; Alexander Kurosky
Journal:  Proteomics Clin Appl       Date:  2009       Impact factor: 3.494

Review 3.  Do eosinophils have a role in the killing of helminth parasites?

Authors:  E N Meeusen; A Balic
Journal:  Parasitol Today       Date:  2000-03

4.  Sulfhydryl regulation of L-selectin shedding: phenylarsine oxide promotes activation-independent L-selectin shedding from leukocytes.

Authors:  T A Bennett; B S Edwards; L A Sklar; S Rogelj
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

5.  Evaluation of Fas2-ELISA for the serological detection of Fasciola hepatica infection in humans.

Authors:  Jose R Espinoza; Vicente Maco; Luis Marcos; Sandra Saez; Victor Neyra; Angelica Terashima; Frine Samalvides; Eduardo Gotuzzo; Elizabeth Chavarry; Maria Cecilia Huaman; M Dolores Bargues; M Adela Valero; Santiago Mas-Coma
Journal:  Am J Trop Med Hyg       Date:  2007-05       Impact factor: 2.345

Review 6.  Annexin A1 and glucocorticoids as effectors of the resolution of inflammation.

Authors:  Mauro Perretti; Fulvio D'Acquisto
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

7.  Calcium ionophore A23187 calcium-dependent cytolytic degranulation in human eosinophils.

Authors:  T Fukuda; S J Ackerman; C E Reed; M S Peters; S L Dunnette; G J Gleich
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

8.  Immunoglobulin E and eosinophil-dependent protective immunity to larval Onchocerca volvulus in mice immunized with irradiated larvae.

Authors:  David Abraham; Ofra Leon; Silvia Schnyder-Candrian; Chun Chi Wang; Ann Marie Galioto; Laura A Kerepesi; James J Lee; Sara Lustigman
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

9.  Retinoic acids are potent inhibitors of spontaneous human eosinophil apoptosis.

Authors:  Shigeharu Ueki; Gulixian Mahemuti; Hajime Oyamada; Hikari Kato; Junko Kihara; Masako Tanabe; Wataru Ito; Takahito Chiba; Masahide Takeda; Hiroyuki Kayaba; Junichi Chihara
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

10.  Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma.

Authors:  A G Rossi; C Haslett; N Hirani; A P Greening; I Rahman; C N Metz; R Bucala; S C Donnelly
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808
View more
  2 in total

Review 1.  Proteomics of Eosinophil Activation.

Authors:  Deane F Mosher; Emily M Wilkerson; Keren B Turton; Alexander S Hebert; Joshua J Coon
Journal:  Front Med (Lausanne)       Date:  2017-09-29

2.  Analysis of Predicted Host-Parasite Interactomes Reveals Commonalities and Specificities Related to Parasitic Lifestyle and Tissues Tropism.

Authors:  Yesid Cuesta-Astroz; Alberto Santos; Guilherme Oliveira; Lars J Jensen
Journal:  Front Immunol       Date:  2019-02-13       Impact factor: 8.786
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.